BEGIN:VCALENDAR
PRODID:-//ics 70.9054//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/Paris
X-LIC-LOCATION:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP;TZID=Europe/Paris:20260305T185817
SUMMARY:WORKSHOP : Cognition in Down syndrome: Molecular, Cellular and Behavioral Features and the Promise of Pharmacotherapeutics
DTSTART;TZID=Europe/Paris:20130413T000000
DTEND;TZID=Europe/Paris:20130415T235959
UID:2013041359
DESCRIPTION:The goal of the Workshop on Cognition in Down Syndrome (Molecular, Cellular and Behavioral Features and the Promise of Pharmacotherapies) is to encourage new collaborations and expanded research directions relevant to cognition in DS and pharmacotherapies for cognition in DS. We invite investigators with interest or expertise in one or more of the following topics to attend: the biology of one or more HSA21 genes; the biology of pathways or cellular processes relevant to the DS cognitive phenotype and in which HSA21 genes function; development and analysis of DS model systems, including segmental trisomy mouse models and neurally differentiated induced pluripotent stem cells (iPSCs); pharmacology relevant to DS cognitive deficits; and assessment of DS neurological and cognitive abnormalities.
Yann Hérault, director of ICS, will attend this meeting through scientific communication.
LOCATION:Washington DC, USA
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR